Eye & Ent Hospital Of Fudan University
Clinical trials sponsored by Eye & Ent Hospital Of Fudan University, explained in plain language.
-
New aggressive treatment strategy tested for rare adult sinus cancer
Disease control ENROLLING_BY_INVITATIONThis study is testing a combination treatment approach for adults with a rare cancer called rhabdomyosarcoma in the nasal cavity and sinuses. The treatment involves chemotherapy, radiation therapy, and surgery in a specific sequence. Researchers want to see how well this approach…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC
-
New combination therapy aims to reduce recurrence in rare lymphoma
Disease control ENROLLING_BY_INVITATIONThis study is testing whether adding the immunotherapy drug tislelizumab to standard chemotherapy and radiation can better control early-stage NK/T-cell lymphoma and reduce the chance of the cancer coming back. The trial will enroll 60 adults with stage I or II disease who haven'…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC